Is Openclaw Security Vaccine Safe?
Openclaw Security Vaccine — Nerq Trust Score 56.6/100 (D grade). Score based on 5 independent trust signals.
Openclaw Security Vaccine is a software tool with a Nerq Trust Score of 56.6/100 (D), based on 5 independent data dimensions. Security: 0/100. Maintenance: 1/100. Popularity: 0/100. Data sourced from multiple public sources including package registries, GitHub, NVD, OSV.dev, and OpenSSF Scorecard. Last updated: n/a. Machine-readable data (JSON).
Is Openclaw Security Vaccine safe?
Trust Score Breakdown — Openclaw Security Vaccine has a Nerq Trust Score of 56.6/100 (D). Measured across 5 independent trust signals.
What is Openclaw Security Vaccine's trust score?
Openclaw Security Vaccine has a Nerq Trust Score of 56.6/100, earning a D grade. This score is based on 5 independently measured dimensions including security, maintenance, and community adoption.
What are the key security findings for Openclaw Security Vaccine?
Openclaw Security Vaccine's strongest signal is compliance at 94/100. No known vulnerabilities have been detected.
What is Openclaw Security Vaccine and who maintains it?
| Author | Clawman-007 |
| Category | Security |
| Source | https://github.com/Clawman-007/openclaw-security-vaccine |
Regulatory Compliance
| EU AI Act Risk Class | MINIMAL |
| Compliance Score | 94/100 |
| Jurisdictions | Assessed across 52 jurisdictions |
Popular Alternatives in security
What Is Openclaw Security Vaccine?
Openclaw Security Vaccine is a security tool: Security scanner for OpenClaw installations.. Nerq Trust Score: 57/100 (D).
Nerq independently analyzes every software tool, app, and extension across multiple trust signals including security vulnerabilities, maintenance activity, license compliance, and community adoption.
How Nerq Assesses Openclaw Security Vaccine's Safety
Nerq's Trust Score is calculated from 13+ independent signals aggregated into five dimensions. Here is how Openclaw Security Vaccine performs in each:
- Security (0/100): Openclaw Security Vaccine's security posture is poor. This score factors in known CVEs, dependency vulnerabilities, security policy presence, and code signing practices.
- Maintenance (1/100): Openclaw Security Vaccine is potentially abandoned. We track commit frequency, release cadence, issue response times, and PR merge rates.
- Documentation (1/100): Documentation quality is insufficient. This includes README completeness, API documentation, usage examples, and contribution guidelines.
- Compliance (94/100): Openclaw Security Vaccine is broadly compliant. Assessed against regulations in 52 jurisdictions including the EU AI Act, CCPA, and GDPR.
- Community (0/100): Community adoption is limited. Based on GitHub stars, forks, download counts, and ecosystem integrations.
The overall Trust Score of 56.6/100 (D) is the weighted combination of these measured signals. It is a measurement, not a pass/fail or suitability judgment — weigh the individual signals against your own requirements.
Who Typically Evaluates Openclaw Security Vaccine?
Openclaw Security Vaccine is commonly evaluated by:
- Developers and teams working with security tools
- Organizations evaluating AI tools for their stack
- Researchers exploring AI capabilities in this domain
How to read the signals: Openclaw Security Vaccine's measured signals (security 0/100, maintenance 1/100, documentation 1/100, community 0/100) are shown above. These are measurements, not a suitability judgment — weigh each signal against the requirements of your own use case and risk tolerance.
How to Verify Openclaw Security Vaccine's Safety Yourself
While Nerq provides automated trust analysis, we recommend these additional steps before adopting any software tool:
- Check the source code — Review the repository's security policy, open issues, and recent commits for signs of active maintenance.
- Scan dependencies — Use tools like
npm audit,pip-audit, orsnykto check for known vulnerabilities in Openclaw Security Vaccine's dependency tree. - Review permissions — Understand what access Openclaw Security Vaccine requires. Software tools should follow the principle of least privilege.
- Test in isolation — Run Openclaw Security Vaccine in a sandboxed environment before granting access to production data or systems.
- Monitor continuously — Use Nerq's API to set up automated trust checks:
GET nerq.ai/v1/preflight?target=openclaw-security-vaccine - Review the license — Confirm that Openclaw Security Vaccine's license is compatible with your intended use case. Pay attention to restrictions on commercial use, redistribution, and derivative works. Some AI tools use dual licensing or have separate terms for enterprise customers that differ from the open-source license.
- Check community signals — Look at the project's issue tracker, discussion forums, and social media presence. A healthy community actively reports bugs, contributes fixes, and discusses security concerns openly. Low community engagement may indicate limited peer review of the codebase.
Common Safety Concerns with Openclaw Security Vaccine
When evaluating whether Openclaw Security Vaccine is safe, consider these category-specific risks:
Understand how Openclaw Security Vaccine processes, stores, and transmits your data. Review the tool's privacy policy and data retention practices, especially for sensitive or proprietary information.
Check Openclaw Security Vaccine's dependency tree for known vulnerabilities. Tools with outdated or unmaintained dependencies pose a higher security risk.
Regularly check for updates to Openclaw Security Vaccine. Security patches and bug fixes are only effective if you're running the latest version.
If Openclaw Security Vaccine connects to external APIs or services, each integration point is a potential attack surface. Audit all third-party connections, verify that data shared with external services is minimized, and ensure that integration credentials are rotated regularly.
Verify that Openclaw Security Vaccine's license is compatible with your intended use case. Some AI tools have restrictive licenses that limit commercial use, redistribution, or derivative works. Using Openclaw Security Vaccine in violation of its license can expose your organization to legal liability.
Openclaw Security Vaccine and the EU AI Act
Openclaw Security Vaccine is classified as Minimal Risk under the EU AI Act. This is the lowest risk category, meaning it faces minimal regulatory requirements. However, transparency obligations still apply.
Nerq's compliance assessment covers 52 jurisdictions worldwide. For organizations deploying AI tools in regulated environments, understanding these classifications is essential for legal compliance.
Best Practices for Using Openclaw Security Vaccine Safely
Whether you're an individual developer or an enterprise team, these practices will help you get the most from Openclaw Security Vaccine while minimizing risk:
Periodically review how Openclaw Security Vaccine is used in your workflow. Check for unexpected behavior, permissions drift, and compliance with your security policies.
Ensure Openclaw Security Vaccine and all its dependencies are running the latest stable versions to benefit from security patches.
Grant Openclaw Security Vaccine only the minimum permissions it needs to function. Avoid granting admin or root access.
Subscribe to Openclaw Security Vaccine's security advisories and vulnerability disclosures. Use Nerq's API to get automated trust score updates.
Create and maintain a clear policy for how Openclaw Security Vaccine is used within your organization, including data handling guidelines and acceptable use cases.
Situations That Warrant Independent Review of Openclaw Security Vaccine
Nerq's signals are one input. In the following situations, evaluate Openclaw Security Vaccine's measured signals against your own requirements before making a decision:
- Environments handling sensitive or regulated data (healthcare, finance, government)
- Mission-critical systems where downtime has significant business impact
- Deployments with strict regulatory requirements that must be independently validated
For each situation, compare Openclaw Security Vaccine's measured trust score of 56.6/100 and its individual signals against your organization's own criteria. Nerq does not assert whether Openclaw Security Vaccine is suitable for any particular use.
How Openclaw Security Vaccine Compares to Industry Standards
Nerq indexes over 6 million software tools, apps, and packages across dozens of categories. Among security tools, the average Trust Score is 67/100. Openclaw Security Vaccine's score of 56.6/100 is below the category average of 67/100.
This suggests that Openclaw Security Vaccine trails behind many comparable security tools. Organizations with strict security requirements should evaluate whether higher-scoring alternatives better meet their needs.
Industry benchmarks matter because they contextualize a tool's safety profile. A score that looks moderate in isolation may actually represent strong performance within a challenging category — or vice versa. Nerq's category-relative analysis helps teams make informed decisions by showing not just absolute quality, but how a tool ranks against its direct peers.
Trust Score History
Nerq continuously monitors Openclaw Security Vaccine and recalculates its Trust Score as new data becomes available. Our scoring engine ingests real-time signals from source repositories, vulnerability databases (NVD, OSV.dev), package registries, and community metrics. When a new CVE is published, a major release ships, or maintenance patterns change, Openclaw Security Vaccine's score is updated within 24 hours.
Historical trust trends reveal whether a tool is improving, stable, or declining over time. A tool that consistently maintains or improves its score demonstrates ongoing commitment to security and quality. Conversely, a downward trend may signal reduced maintenance, growing technical debt, or unresolved vulnerabilities. To track Openclaw Security Vaccine's score over time, use the Nerq API: GET nerq.ai/v1/preflight?target=openclaw-security-vaccine&include=history
Nerq retains trust score snapshots at regular intervals, enabling trend analysis across weeks and months. Enterprise users can access detailed historical reports showing how each dimension — security, maintenance, documentation, compliance, and community — has evolved independently, providing granular visibility into which aspects of Openclaw Security Vaccine are strengthening or weakening over time.
Openclaw Security Vaccine vs Alternatives
In the security category, Openclaw Security Vaccine scores 56.6/100. There are higher-scoring alternatives available. For a detailed comparison, see:
- Openclaw Security Vaccine vs Ciphey — Trust Score: 63.4/100
- Openclaw Security Vaccine vs strix — Trust Score: 64.4/100
- Openclaw Security Vaccine vs SWE-agent — Trust Score: 76.9/100
Key Takeaways
- Openclaw Security Vaccine has a measured Nerq Trust Score of 56.6/100 (D) — a composite of independent signals, not a suitability judgment.
- Among security tools, Openclaw Security Vaccine scores below the category average of 67/100 (a positional measurement relative to peers).
- The individual signals — security, maintenance, documentation, compliance, community — are shown above. Weigh them against your own requirements.
- Query the current measured values via Nerq's Preflight API.
Frequently Asked Questions
Is Openclaw Security Vaccine Safe?
What is Openclaw Security Vaccine's trust score?
What are safer alternatives to Openclaw Security Vaccine?
How often is Openclaw Security Vaccine's safety score updated?
Can I use Openclaw Security Vaccine in a regulated environment?
See Also
Disclaimer: Nerq trust scores are automated measurements based on publicly available signals. They are not endorsements, verdicts, or guarantees of suitability. Always evaluate the signals against your own requirements.